Put companies on watchlist
DKSH Management Ltd.
ISIN: CH0126673539
WKN: A1JU9U
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

DKSH Management Ltd. · ISIN: CH0126673539 · EQS - Company News (58 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 2101996
18 March 2025 07:00AM

DKSH Technology Acquires Taqkey Science and Quantum Biotech, Two Technology Distribution Companies in Taiwan


DKSH Management Ltd. / Key word(s): Takeover
DKSH Technology Acquires Taqkey Science and Quantum Biotech, Two Technology Distribution Companies in Taiwan

18.03.2025 / 07:00 CET/CEST


Media release

DKSH has signed an agreement to acquire Taqkey Science (“Taqkey”) and Quantum Biotech (“Quantum”) in Taiwan. With these transactions, DKSH Technology further extends its scientific solutions and consumables businesses in line with the Business Units’ strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Zurich, Switzerland, March 18, 2025 – DKSH has announced today that it signed an agreement to acquire Taqkey and Quantum, two life science reagent and consumables distribution companies in Taiwan. The distributed products encompass reagents and consumables for molecular biology, genetic engineering, and cell-based therapies. Thus, DKSH Technology further anchors its regional presence in the life science industry in Asia-Pacific.

Founded in 2002, Taqkey is headquartered in Miaoli, Taiwan. Together with Quantum, the company employs more than 60 people and generates annual net sales of more than CHF 13 million1 at good profitability and builds on successful, longstanding relationships with renowned blue-chip clients from the life science industry. The Group operates seven sales offices and three warehouses across Taiwan.

Hanno Elbraechter, Head Business Unit Technology at DKSH, said: “With Taqkey, we will further grow our consumables business in the life science industry of Asia-Pacific and thus solidify our position as a leading scientific solutions provider in the region. We are delighted to jointly leverage Taqkey’s attractive client and customer portfolio, and the synergies created by our joint operations.”

Jeffrey Cheung, Founder and Managing Director of Taqkey, commented: “We are excited about our shared future with DKSH, a leading technology solutions provider in Asia Pacific. As DKSH will benefit from our longstanding client and customer relationships in Taiwan, we will be happy to leverage DKSH’s broad expertise and to use existing sales channels to further grow our business. We are confident this step will positively impact all our business partners as well as our valued employees.”

The closing of the transaction is expected during the second quarter of 2025 and is subject to certain conditions.

1 Exchange rate 1 Swiss Franc / 36.9 TWD

About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec  

For more information please contact:

DKSH Holding Ltd.

Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com

Melanie Grüter
Manager Group Media Relations
Phone +41 44 386 7211
melanie.grueter@dksh.com



End of Media Release


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 2101996

 
End of News EQS News Service

2101996  18.03.2025 CET/CEST

Visual performance / price development - DKSH Management Ltd.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.